Table 3 The status of the vacA, cagA and babA2 genotypes in patients with gastric diseases
| Â | Diagnosis | p value (x2test) | |||
|---|---|---|---|---|---|
CSG n(%) | CAG n(%) | Peptic ulcer n(%) | Gastric erosion n(%) | ||
H. pylori | |||||
 Negative | 72 (53.7) | 9 (6.7) | 11 (8.2) | 26 (19.4) | 0.509 |
 Positive | 45 (33.6) | 8 (6) | 10 (7.5) | 26 (19.4) |  |
vacA s1 | |||||
 Negative | 21 (46.7) | 3 (37.5) | 2 (20) | 12 (46.2) | 0.456 |
 Positive | 24 (53.3) | 5 (62.5) | 8 (80) | 14 (53.8) |  |
vacA m1 | |||||
 Negative | 40 (88.9) | 6 (75) | 8 (80) | 23 (88.5) | 0.665 |
 Positive | 5 (11.1) | 2 (25) | 2 (20) | 3 (11.5) |  |
cagA | |||||
 Negative | 35 (77.8) | 4 (50) | 7 (70) | 19 (73.1) | 0.414 |
 Positive | 10 (22.2) | 4 (50) | 3 (30) | 7 (26.9) |  |
babA2 | |||||
 Negative | 32 (71.1) | 7 (87.5) | 6 (60) | 19 (73.1) | 0.638 |
 Positive | 13 (28.9) | 1 (12.5) | 4 (40) | 7 (26.9) |  |
p value (x2 test) | 0.000 | 0.149 | 0.037 | 0.009 | Â |